Latest:
Dr. Chu on Ongoing Efforts to Address Disparities in Lung Cancer
Edward Chu, MD, MMS, discusses ongoing efforts to address disparities in lung cancer at Montefiore and Albert Einstein College of Medicine.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Victoria Villaflor, MD, Clinical Professor, Director Head and Neck Oncology, City of Hope
Latest:
Rethinking How We Approach Stage 3 Lung Cancer Treatment
As ongoing research continues to unlock the mechanisms of non–small cell lung cancer, it’s becoming increasingly clear that healthcare providers need to start rethinking how treatment is approached—especially for Stage 3 disease.
Michael S. Leapman, MD, MHS
Latest:
Dr. Leapman on Factors Influencing the Decision to Undergo Genomic Testing in Prostate Cancer
Michael S. Leapman, MD, MHS, discusses key factors that influence patient experiences with biopsy-based genomic testing during active surveillance for prostate cancer, and how to best address them in clinical practice.